Analysts appear optimistic for Intellia’s gene editor nex-z, which showed a greater serum TTR reduction than Alnylam’s ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Ania Turska is going through 'intensive' therapy to regain her ability to walk and talk, after being placed in a medically ...

A recent study published in the Journal of the American Geriatrics Society revealed that age-associated hearing loss (AAHL) ...